We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Celgene Provides REVLIMID® Regulatory Update

News   Feb 12, 2013

 
Celgene Provides REVLIMID® Regulatory Update
 
 
 

RELATED ARTICLES

Making Malignant Brain Tumors Self-Destruct

News

Aggressive brain tumour cells taken from patients self-destructed after being exposed to a chemical in laboratory tests

READ MORE

HIV Therapy Reduces Virus and Boosts Immunity in Drug-Resistant Patients

News

A new HIV drug reduced viral replication and increased immune cells in individuals with advanced, drug-resistant HIV infection. Used in combination with existing HIV medications, the drug is a promising strategy for patients who have run out of effective treatment options.

READ MORE

Blood Test Could Detect Kidney Cancer Up to Five Years Earlier

News

Scientists have discovered that a marker in the blood could help predict the risk that a person will develop kidney cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE